Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-015047
Filing Date
2020-06-03
Accepted
2020-06-03 16:07:39
Documents
1
Period of Report
2020-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4308
  Complete submission text file 0000899243-20-015047.txt   5761
Mailing Address C/O EIDOS THERAPEUTICS, INC. 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94101
Business Address
Sinha Uma (Reporting) CIK: 0001742587 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38959 | Film No.: 20940054

Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations